Clinicians are not convinced of the efficacy of the combination given the conflicting data. It would be “hard to translate the confusing contradictory datasets to my clinical practice,” says Murray Raskind, MD.
FDA panel rejects brexpiprazole-sertraline combo for PTSD
Medscape | July 22, 2025
